Survodutide Guide
The GLP-1/Glucagon Dual Agonist for
Complete guide to Survodutide (BI 456906) - Boehringer Ingelheim
What Is Survodutide?
Survodutide (BI 456906) is a dual receptor agonist developed by Boehringer Ingelheim in partnership with Zealand Pharma. It activates both GLP-1 receptors (like Ozempic) and glucagon receptors—a unique combination that targets both appetite and metabolism.
Why glucagon? While glucagon is often associated with raising blood sugar, when combined with GLP-1, it dramatically increases energy expenditure and promotes fat burning—especially in the liver. This makes Survodutide particularly promising for fatty liver disease.
Administration: Once-weekly subcutaneous injection, similar to other GLP-1 medications.
The Dual Mechanism
Breakthrough MASH Results
Weight Loss Results
Expected Dosing Schedule
Side Effects
Development Timeline
Who Will Benefit Most?
Vital Protocol FAQs
Guide FAQs
Complete guide to Survodutide (BI 456906) - Boehringer Ingelheim
Yes. Shotlee supports tracking Survodutide doses, side effects, and health metrics. It is free to use.
PubMed, ClinicalTrials.gov, and the FDA website are the most reliable sources for current Survodutide research and regulatory updates. Peer-reviewed journals including the New England Journal of Medicine, The Lancet, and JAMA publish the most impactful clinical trial results. This guide is updated regularly to reflect the latest available evidence. Use Shotlee to track your personal protocol outcomes alongside the published research.
Before starting Survodutide, establish baseline measurements including body weight, waist circumference, blood pressure, and relevant lab work with your healthcare provider. Download Shotlee and begin logging your baseline metrics at least one week before starting treatment. This pre-treatment data provides the comparison point needed to objectively evaluate your treatment response over time. Additionally, discuss potential side effects and management strategies with your prescriber so you are prepared for the initial adaptation phase.
Evidence-based lifestyle modifications that complement Survodutide protocols include: maintaining adequate protein intake (1.2-1.6g per kg body weight per day) to preserve lean mass, performing resistance training two to three times per week, staying well hydrated with at least eight glasses of water daily, prioritizing seven to nine hours of quality sleep, managing stress through regular physical activity or mindfulness practices, and eating smaller more frequent meals during dose titration phases. Track these lifestyle factors alongside your Survodutide data in Shotlee to identify which combinations drive your best results.
Track Your Survodutide Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.